Optimizing Chemoradiotherapy to Target Metastatic Disease and Tumor Growth

References

• Awwad H (2013) Radiation Oncology: Radiobiological and Physiological Perspectives: The Boundary-Zone between Clinical Radiotherapy and Fundamental Radiobiology and Physiology, Vol. 60 (Springer Science & Business Media, Dordrecht, Netherlands).Google Scholar
• Badri H, Ramakrishnan J, Leder K (2015b) Minimizing metastatic risk in radiotherapy fractionation schedules. Phys. Medicine Biol. 60(22):N405–N417.Crossref, Google Scholar
• Badri H, Watanabe Y, Leder K (2016) Optimal radiotherapy dose schedules under parametric uncertainty. Phys. Medicine Biol. 61(1):338–364.Crossref, Google Scholar
• Badri H, Pitter K, Holland E, Michor F, Leder K (2015a) Optimization of radiation dosing schedules for proneural glioblastoma. J. Math. Biol. 72(5):1301–1306.Crossref, Google Scholar
• Bortfeld T, Ramakrishnan J, Tsitsiklis JN, Unkelbach J (2015) Optimization of radiation therapy fractionation schedules in the presence of tumor repopulation. INFORMS J. Comput. 27(4): 788–803.Link, Google Scholar
• Brenner D (2008) The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Seminars Radiation Oncology 18(4):234–239.Crossref, Google Scholar
• Britten R, Evans A, Allalunis-Turner M, Pearcey R (1996) Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines. Internat. J. Radiation Oncology Biol. Phys. 34(2):367–374.Crossref, Google Scholar
• Carlson V, Delclos L, Fletcher G (1967) Distant metastases in squamous-cell carcinoma of the uterine cervix 1. Radiology 88(5): 961–966.Crossref, Google Scholar
• Chaffer C, Weinberg R (2011) A perspective on cancer cell metastasis. Science 331(6024):1559–1564.Crossref, Google Scholar
• Chalmers A, Ruff E, Martindale C, Lovegrove N, Short S (2009) Cytotoxic effects of temozolomide and radiation are additive-and schedule-dependent. Internat. J. Radiation Oncology Biol. Phys. 75(5):1511–1519.Crossref, Google Scholar
• Chankong V, Haimes Y (1983) Multiobjective Decision Making: Theory and Methodology (North-Holland, Amsterdam).Google Scholar
• Dai X, Ding J, Zhang R, Ren J, Ma C, Wu G (2013) Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway. Internat. J. Radiation Biol. 89(9):724–731.Crossref, Google Scholar
• Dale R, Coles I, Deehan C, Donoghue JO (1997) Calculation of integrated biological response in brachytherapy. Internat. J. Radiation Oncology Biol. Phys. 38(3):633–642.Crossref, Google Scholar
• Eifel P, Winter K, Morris M, Levenback C, Grigsby P, Cooper J, Rotman M, Gershenson D, Mutch D (2004) Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01. J. Clinical Oncology 22(5):872–880.Crossref, Google Scholar
• Farhidzadeh H, Zhou M, Goldgof DB, Hall LO, Raghavan M, Gatenby RA (2014) Prediction of treatment response and metastatic disease in soft tissue sarcoma. SPIE Medical Imaging (International Society for Optics and Photonics, Bellingham, WA), 903518.Google Scholar
• Farhidzadeh H, Chaudhury B, Scott J, Goldgof D, Hall L, Gatenby R, Gillies R, Raghavan M (2016) Signal intensity analysis of ecological defined habitat in soft tissue sarcomas to predict metastasis development. SPIE Medical Imaging (International Society for Optics and Photonics, Bellingham, WA), 97851H.Google Scholar
• Fehlauer F, Barten-Van R AD, Stalpers LJ, Leenstra S, Lindeman J, Tjahja I, Troost D, Wolbers JG, van der Valk P, Sminia P (2000) Additive cytotoxic effect of cisplatin and X-irradiation on human glioma cell cultures derived from biopsy-tissue. J. Cancer Res. Clinical Oncology 126(12):711–716.Crossref, Google Scholar
• Foo J, Michor F (2010) Evolution of resistance to anti-cancer therapy during general dosing schedules. J. Theoret. Biol. 263(2):179–188.Crossref, Google Scholar
• Franken NAP, Hovingh S, Rodermond H, Stalpers L, Barendsen GW, Crezee J (2012) Radiosensitization with chemotherapeutic agents and hyperthermia: Effects on linear-quadratic parameters of radiation cell survival curves. J. Cancer Sci. Therapy S5:002.Google Scholar
• Friberg S, Mattson S (1997) On the growth rates of human malignant tumors: Implications for medical decision making. J. Surgical Oncology 65(4):284–297.Crossref, Google Scholar
• Grassberger C, Paganetti H (2016) Methodologies in the modeling of combined chemo-radiation treatments. Phys. Medicine Biol. 61(21):R344–R369.Crossref, Google Scholar
• Green J, Kirwan J, Tierney J, Symonds P, Fresco L, Collingwood M,Williams C (2001) Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. The Lancet 358(9284):781–786.Crossref, Google Scholar
• Gupta G, Massagué J (2006) Cancer metastasis: Building a framework. Cell 127(4):679–695.Crossref, Google Scholar
• Haeno H, Gonen M, Davis M, Herman J, Iacobuzio-Donahue C, Michor F (2012) Computational modeling of pancreatic cancer progression reveals dynamics of growth and dissemination and suggests optimum treatment strategies. Cell 148:362–375.Crossref, Google Scholar
• Hall E, Giaccia A (2006) Radiobiology for the Radiologist (Lippincott Williams & Wilkins, Philadelphia).Google Scholar
• Hanahan D, Weinberg R (2000) The hallmarks of cancer. Cell 100(1): 57–70.Crossref, Google Scholar
• Hanin L, Korosteleva O (2010) Does extirpation of the primary breast tumor give boost to growth of metastases? Evidence revealed by mathematical modeling. Math. Biosciences 223(2):133–141.Crossref, Google Scholar
• Hanin L, Pavlova L (2013) Optimal screening schedules for prevention of metastatic cancer. Statist. Medicine 32(2):206–219.Crossref, Google Scholar
• Hanin L, Rose J, Zaider M (2006) A stochastic model for the sizes of detectable metastases. J. Theoret. Biol. 243(3):407–417.Crossref, Google Scholar
• Hess K, Varadhachary G, Taylor S, Wei W, Raber M, Lenzi R, Abbruzzese J (2006) Metastatic patterns in adenocarcinoma. Cancer 106(7):1624–1633.Crossref, Google Scholar
• Iwata K, Kawasaki K, Shigesada N (2000) A dynamical model for the growth and size distribution of multiple metastatic tumors. J. Theoret. Biol. 203(2):177–186.Crossref, Google Scholar
• Jaeger K, Merlo F, Kavanagh M, Fyles A, Hedley D, Hill R (1998) Heterogeneity of tumor oxygenation: Relationship to tumor necrosis, tumor size, and metastasis. Internat. J. Radiation Oncology Biol. Phys. 42(4):717–721.Crossref, Google Scholar
• Joiner M, van der Kogel A (2009) Basic Clinical Radiobiology, 4th ed. (CRC Press, Boca Raton, FL).Crossref, Google Scholar
• Jones B, Dale R (2005) The potential for mathematical modelling in the assessment of the radiation dose equivalent of cytotoxic chemotherapy given concomitantly with radiotherapy. The British J. Radiology 78(934):939–944.Crossref, Google Scholar
• Keys H, Bundy B, Stehman F, Muderspach L, Chafe W, Suggs C, Walker J, Gersell D (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IV cervical carcinoma. New England J. Medicine 340(15):1154–1161.Crossref, Google Scholar
• Kirkpatrick J, Meyer J, Marks L (2008) The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Seminars Radiation Oncology 18(4):240–243.Crossref, Google Scholar
• Lartigau E, Lusinchi A, Weeger P, Wibault P, Luboinski B, Eschwege F, Guichard M (1998) Variations in tumour oxygen tension (pO2) during accelerated radiotherapy of head and neck carcinoma. Eur. J. Cancer 34(6):856–861.Crossref, Google Scholar
• Lin J, Jan J, Hsu C, Liang W, Jiang R, Wang W (2003) Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival. J. Clinical Oncology 21(4):631–637.Crossref, Google Scholar
• McCall J, Petrovski A, Shakya S (2008) Evolutionary Algorithms for Cancer Chemotherapy Optimization (John Wiley & Sons, Inc., Hoboken, NJ).Google Scholar
• Mizuta M, Takao S, Date H, Kishimotoi N, Sutherland K, Onimaru R, Shirato H (2012) A mathematical study to select fractionation regimen based on physical dose distribution and the linear-quadratic model. Internat. J. Radiation Oncology Biol. Phys. 84(3):829–833.Crossref, Google Scholar
• Mould D, AC Walz A, Lave T, Gibbs J, Frame B (2015) Developing exposure/response models for anticancer drug treatment: Special considerations. CPT: Pharmacometrics Systems Pharmacology 4(1):1–16.Crossref, Google Scholar
• Nahum AE, Tait DM (1992) Maximizing local control by customized dose prescription for pelvic tumours. Breit A, Heuck A, Lukas P, Kneschaurek P, Mayr M, eds. Tumor Response Monitoring and Treatment Planning (Springer, Berlin), 425–431.Crossref, Google Scholar
• Nishimura Y (2004) Rationale for chemoradiotherapy. Internat. J. Clinical Oncology 9(6):414–420.Crossref, Google Scholar
• Peters W, Liu P, Barrett R, Stock R, Monk B, Berek J, Souhami L, Grigsby P, Gordon W, Alberts D (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clinical Oncology 18(8):1606–1613.Crossref, Google Scholar
• Plataniotis G, Dale R (2008) Use of concept of chemotherapy-equivalent biologically effective dose to provide quantitative evaluation of contribution of chemotherapy to local tumor control in chemoradiotherapy cervical cancer trials. Internat. J. Radiation Oncology Biol. Phys. 72(5):1538–1543.Crossref, Google Scholar
• Portelance L, Chao K, Grigsby P, Bennet H, Low D (2001) Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Internat. J. Radiation Oncology Biol. Phys. 51(1):261–266.Crossref, Google Scholar
• Roodman G (2004) Mechanisms of bone metastasis. New England J. Medicine 350(16):1655–1664.Crossref, Google Scholar
• Saberian F, Ghate A, Kim M (2016) A theoretical stochastic control framework for adapting radiotherapy to hypoxia. Phys. Med. Biol. 61(19):7136–7161.Crossref, Google Scholar
• Sachs R, Brenner D (2005) Solid tumor risks after high doses of ionizing radiation. Proc. National Acad. Sci. USA 102(37):13040–13045.Crossref, Google Scholar
• Salari E, Unkelbach J, Bortfeld T (2015) A mathematical programming approach to the fractionation problem in chemoradiotherapy. IIE Trans. Healthcare Systems Engrg. 5(2):55–73.Crossref, Google Scholar
• Seiwert T, Salama J, Vokes E (2007) The concurrent chemoradiation paradigm–General principles. Nature Clinical Practice Oncology 4(2):86–100.Crossref, Google Scholar
• Skipper HE, Schabel FW, Wilcox WS (1964) Experimental evaluation of potential anticancer agents. XIII. On the criteria and kinetics associated with “curability” of experimental leukemia. Cancer Chemotherapy Rep. Part 1 35:1–111.Google Scholar
• Steel G, Peckham M (1979) Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity. Internat. J. Radiation Oncology Biol. Phys. 5(1):85–91.Crossref, Google Scholar
• Vokes E, Weichselbaum R (1990) Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J. Clinical Oncology 8(5):911–934.Crossref, Google Scholar
• Wang J, Mayr N, Yuh W, Motebello J, Zhang H, Gupta N, Grecula J, Wu D (2006) 2708: Kinetic model of tumor regression during radiation therapy of cervical cancer. Internat. J. Radiation Oncology Biol. Phys. 66(3):S603.Crossref, Google Scholar
• Wee J, Tan E, Tai B, Wong H, Swan SL, Tan T, Chua E, Yang E, Lee K, Fong Ket al. (2005) Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American joint committee on cancer/international union against cancer stage iii and iv nasopharyngeal cancer of the endemic variety. J. Clinical Oncology 23(27):6730–6738.Crossref, Google Scholar
• Wein L, Cohen J, Wu J (2000) Dynamic optimization of a linear–quadratic model with incomplete repair and volume-dependent sensitivity and repopulation. Internat. J. Radiation Oncology Biol Phys. 47(4):1073–1083.Crossref, Google Scholar
• Wigg D (2001) Applied Radiobiology and Bioeffect Planning (Medical Physics Publishing, Madison, WI).Google Scholar
• Wouters B, Brown J (1997) Cells at intermediate oxygen levels can be more important than the “hypoxic fraction” in determining tumor response to fractionated radiotherapy. Radiation Res. 147(5):541–550.Crossref, Google Scholar